These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Combination pharmacotherapy therapy in the management of atherogenic dyslipidemia]. Kłosiewicz-Latoszek L; Cybulska B Kardiol Pol; 2005 Jun; 62 Suppl 2():II76-80. PubMed ID: 19813341 [No Abstract] [Full Text] [Related]
5. [The best srategies to optimize lipid control: increasing statins dose or ezetimibe coadministration?]. Polo Romero FJ; Santisteban López Y; Ramírez Relinque L; Rodríguez Martín B Rev Clin Esp; 2010 Sep; 210(8):425-6; author reply 426-7. PubMed ID: 20673662 [No Abstract] [Full Text] [Related]
6. Simvastatin + ezetimibe: a combination with no proven advantages. Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17460829 [No Abstract] [Full Text] [Related]
7. [How can lipid therapy be improved? Cardiologists insist on dual cholesterol inhibition]. MMW Fortschr Med; 2005 Nov; 147(45):54. PubMed ID: 16320655 [No Abstract] [Full Text] [Related]
8. Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics. Landesman KA; Stozek M; Freeman NJ Conn Med; 1999 Aug; 63(8):455-7. PubMed ID: 10500341 [TBL] [Abstract][Full Text] [Related]
9. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety. Hou R; Goldberg AC Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513 [TBL] [Abstract][Full Text] [Related]
11. I have had trouble controlling my cholesterol with a statin alone. Should I consider prescription niacin? Johns Hopkins Med Lett Health After 50; 2010 Feb; 21(12):8. PubMed ID: 20344817 [No Abstract] [Full Text] [Related]
12. [Cholesterol goals are now easier to reach. Half LDL cholesterol with only one tablet daily]. MMW Fortschr Med; 2005 Nov; 147(45):55. PubMed ID: 16320656 [No Abstract] [Full Text] [Related]
13. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol. Gotto AM; Farmer JA Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799 [TBL] [Abstract][Full Text] [Related]
14. Treatment of hyperlipidemia in elderly persons with exercise training, nonpharmacologic therapy, and drug combinations. Lavie CJ Am J Geriatr Cardiol; 2004; 13(3 Suppl 1):29-33. PubMed ID: 15133427 [TBL] [Abstract][Full Text] [Related]
15. [When should an association of lipid-lowering drugs be proposed in a patient failing to reach therapeutic targets under monotherapy? Guidelines of the New French Society of Atherosclerosis]. Farnier M; Bonnet F; Bruckert E; Ferrières J; Paillard F; Arch Mal Coeur Vaiss; 2007; 100(6-7):569-81. PubMed ID: 17893640 [No Abstract] [Full Text] [Related]
16. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy. Fazio S Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268 [TBL] [Abstract][Full Text] [Related]
17. On the road to better dyslipidemia outcomes. Hughes S Nurse Pract; 2009 Feb; 34(2):14-21; quiz 22. PubMed ID: 19155874 [No Abstract] [Full Text] [Related]
18. [New indications and therapeutic objectives for dyslipidemia]. Maiques Galán A Aten Primaria; 2006 Nov; 38(9):473-5. PubMed ID: 17194348 [No Abstract] [Full Text] [Related]
19. Ezetimibe offers new opportunity to lower LDL-C to target levels. Cardiovasc J S Afr; 2005; 16(3):174. PubMed ID: 16049593 [No Abstract] [Full Text] [Related]